This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Christopher Lipinski: Innovator in Cardiac Treatment
Introduction
Christopher Lipinski is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medical science, particularly in the treatment of cardiac arrest and stroke. His innovative approach focuses on utilizing benzoquinoid ansamycins to combat oxidative-stress induced cell death.
Latest Patents
Lipinski holds a patent for his invention titled "Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke." This patent outlines a method for inhibiting oxidative-stress induced cell death in cells by contacting them with a composition that includes a benzoquinoid ansamycin. Furthermore, it describes a method for reducing neurological injury resulting from cardiac arrest or stroke by administering a composition containing a benzoquinoid ansamycin to patients. He has 1 patent to his name.
Career Highlights
Christopher Lipinski is affiliated with the University of Pittsburgh, where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of patients suffering from cardiac conditions.
Collaborations
Some of his notable coworkers include Clifton W Callaway and Nianqing Xiao, who have collaborated with him on various research projects.
Conclusion
Christopher Lipinski's contributions to medical science through his innovative patent demonstrate his commitment to improving patient outcomes in critical health situations. His work exemplifies the importance of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile